| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
AI technologies are used to analyze medical images with greater speed and precision |
assist in detecting abnormalities such as tumors or fractures, and enhance early diagnosis |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
The main decision remains with the doctor. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
In today's world, AI plays a huge role. |
Humans have been developing and researching Al all along. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
Color is just a matter of human vision. |
Humans will believe in things that are reasonable. which AI can do there |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Professional is already reliable. |
They study directly about that thing. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
This is because newly graduated doctors will not have much experience. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
Humans are the producers of AI. Humans are therefore the center. |
It's the reason humans still have to be in control. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
Ease of use and the tangible benefits it provides to healthcare workers and patients. |
Without AI, doctors' jobs may be difficult. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
AI is controlled by humans. |
patient safety, privacy, fairness, and transparency. Ensuring that AI adheres to these values is critical for fostering trust and widespread adoption in medical settings. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Prioritizing speed over accuracy in diagnostics |
|
AI can replace time |
AI is always faster and more accurate in doing things. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Parkinson's disease is characterized by the degeneration of dopamine-producing neurons in the brain. |
which leads to motor and non-motor symptoms. Stem cell-derived dopamine neurons aim to restore dopamine levels and improve the function of affected neural circuits. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
Non-human primates are commonly used in advanced preclinical studies for Parkinson’s. |
Their brain structure and function closely resemble those of humans, making them ideal for assessing the safety and efficacy of stem cell-based therapies. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
6 months |
|
This period is usually sufficient to assess long-term safety and side effects. |
That may arise from treatment in animal models before moving to clinical trials in humans. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
This phase typically includes elements of both Phase 1 (safety and dosing) and Phase 2 (efficacy and side effects) trials. |
Focus is on preliminary safety assessment and potential treatment effects in a small group of patients. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
Ensures that the product is consistently produced and controlled according to high-quality standards. |
Which is crucial for clinical trials and eventual commercialization, particularly for stem cell-based therapies. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
This outcome indicates that the product did not cause significant harm. |
Abnormal growth, which is a critical factor in determining its safety for further testing in clinical trials.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
This suggests that the stem cell therapy was effective in addressing one of the major symptoms of Parkinson’s |
Disease by improving motor function, which is a promising result for the potential treatment of the disease. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
LMX1A and EN1 |
|
These markers are commonly associated with the differentiation of dopaminergic neurons, which are crucial for the treatment of Parkinson's. |
The presence of LMX1A and EN1 indicates that the stem cells have been properly directed to differentiate into the desired neuronal subtype.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
These growth factors are crucial in guiding the differentiation of stem cells into specific types of neurons. |
Which are necessary for the treatment of Parkinson's disease. They help ensure the stem cells develop into the appropriate neural cells required for the therapy. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
This is a critical measure in evaluating treatments for Parkinson's. |
Disease, as motor function deficits are one of the primary symptoms of the condition. The goal of the STEM-PD therapy is to improve or restore motor abilities in rats, mimicking the desired outcomes in humans. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|